91ÉçÇø

Oral Anticoagulation Therapy Certificate Program

Oral anticoagulation therapy is associated with an increased risk for adverse drug events leading to emergency department visits and readmission to acute care facilities. Since the 1960s warfarin was utilized to improve patient outcomes. Despite the challenges associated with its use, warfarin remains a foundational drug for patients. Health care professionals who care for patients requiring these medications must remain knowledgeable on the current guidelines and best practices to improve patient outcomes.

>>View all our Anticoagulation Programs

Who Should Enroll in this Program?

This program is designed for English-speaking nurses and pharmacists involved in the management of patients requiring oral anticoagulation therapy. Other members of the healthcare team involved in the management of patients requiring oral anticoagulation therapy may be interested in the content as well.

Learning Outcome

The learning outcome of this program is to enable the learner to distinguish the differences and similarities between the oral anticoagulant drugs and employ the current therapeutic guidelines and best practices in managing anticoagulation therapy through interprofessional collaborative practice.

Objectives

At the conclusion of this program, participants will be able to:

1. Define the terms platelet adhesion, platelet activation, and platelet aggregation.
2. Describe the general process of hemostasis, including the sequence of the three stages that prevent blood loss.
3. Explain the role of the vascular endothelium, platelets, circulating clotting factors, endogenous anticoagulants, and thrombolytic proteins in the coagulation process.
4. Briefly describe the series of events that occur in the extrinsic pathway, the intrinsic (contact) pathway, and the common pathway.
5. Define the major functions of thrombin and fibrin in the clotting cascade.
6. Define how activation proteins (proteins C and S) are produced and the role of vitamin K in their production.
7. Identify and discuss the mechanisms, pharmacokinetics, pharmacodynamics, dosing, monitoring, adverse effects, and management of warfarin.
8. Compare and contrast the pharmacokinetics, pharmacodynamics, dosing, monitoring, adverse effects and management of the direct acting oral anticoagulants.
9. Identify and discuss the role of antithrombotic and thrombolytic drugs in valvular disease, atrial fibrillation, and stroke.
10. Apply the current clinical guidelines when choosing the appropriate anticoagulation therapy for patients with VTE and atrial fibrillation.
11. Assimilate evidence based interprofessional collaborative practice.

Criteria for Successful Completion

• Submit registration and payment.
• A certificate for contact hours will be provided following the completion of case-study analysis and submission of the program evaluation. Following review of the content, the learner will apply the content to patient case studies to demonstrate problem solving and decision-making strategies.

The certificate of completion will be sent via autogenerated email immediately upon the completion of the program evaluation.

Contact Hours (10 Contact Hours)

The 91ÉçÇø Center for Health Professions Lifelong Learning designates this activity for 10 contact hours related to pharmacotherapeutics for nurses. This content meets the pharmacology continuing education requirements for the renewal of the advanced practice registered nurse prescriptive authority license.

The 91ÉçÇø Center for Health Professions Lifelong Learning designates this knowledge-based Accreditation Council for Pharmacy Education (ACPE) activity for 10 contact hours for completion of this program. Pharmacists who request to have their contact hours reported to the Certified Pharmacy Education Monitor (CPE) must indicate this request during registration and include the correct NABP e-PID# and Birthdate (mmdd).

The 91ÉçÇø Center for Health Professions Lifelong Learning designates this activity for a maximum of 10.0 AMA PRA Category 1 Creditsâ„¢. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this program does not guarantee expertise in the content. Clinical experience and judgment, coupled with an understanding of the content, are necessary to attain competency. Achieving certification via a designated professional organization is an additional step to demonstrate competency.

Enrollment Cost - $260

The fee includes access to the program, along with all resources and handouts. A textbook, if applicable, is not included in the fee.

If registering by invoicing your employer, program access is granted after payment is received. There is a $25.00 fee to invoice.

Pharmacists who request to have their contact hours reported to the Certified Pharmacy Education Monitor (CPE) must indicate this request during registration and include the correct NABP e-PID# and Birthdate (mmdd). NOTE: CE reporting should be requested during registration. There is an additional $50.00 charge for reporting.

Refund Policy

A $75 administrative fee will be charged prior to accessing the program. No refund will be provided after the program has been accessed.

Questions? Call toll-free 1-877-91ÉçÇø-HLTH (874-4584) or 812-461-5217 or emailÌýusi1nhpcert@usi.edu